Loading…
Enzymatic synthesis of the core-2 sialyl Lewis X O-glycan on the tumor-associated MUC1a’ peptide
Starting from a tumor-associated synthetic MUC1-derived peptide MUC1a’ and using a completely enzymatic approach for the synthesis of the core-2 sialyl Lewis X glycopart, the following glycopeptide was synthesized: AHGV{Neu5Ac(α2-3)Gal(β1-4)[Fuc(α1-3)]GlcNAc(β1-6)[Gal(β1-3)]GalNAc(α1-O)}TSAPDTR. Fir...
Saved in:
Published in: | Biochimie 2003-03, Vol.85 (3), p.275-286 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Starting from a tumor-associated synthetic MUC1-derived peptide MUC1a’ and using a completely enzymatic approach for the synthesis of the core-2 sialyl Lewis X glycopart, the following glycopeptide was synthesized: AHGV{Neu5Ac(α2-3)Gal(β1-4)[Fuc(α1-3)]GlcNAc(β1-6)[Gal(β1-3)]GalNAc(α1-O)}TSAPDTR. First, polypeptide
N-acetylgalactosaminyltransferase 3 was used to site-specifically glycosylate MUC1a’ to give MUC1a’-GalNAc. Then, in a one-pot reaction employing β-galactosidase and core-2 β6-
N-acetylglucosaminyltransferase the core-2 O-glycan structure was prepared. The core-2 structure was then sequentially galactosylated, sialylated, and fucosylated by making use of β4-galactosyltransferase 1, α3-sialyltransferase 3, and α3-fucosyltransferase 3, respectively, resulting in the sialyl Lewis X glycopeptide. The overall yield of the final compound was 23% (3.2 mg, 1.4 μmol). During the synthesis three intermediate glycopeptides containing O-linked GalNAc, Gal(β1-4)GlcNAc(β1-6)[Gal(β1-3)]GalNAc, and Neu5Ac(α2-3)Gal(β1-4)GlcNAc(β1-6)[Gal(β1-3)]GalNAc, respectively, were isolated in mg quantities. All products were characterized by mass spectrometry and NMR spectroscopy. |
---|---|
ISSN: | 0300-9084 1638-6183 |
DOI: | 10.1016/S0300-9084(03)00050-6 |